Blood pressure medication voluntarily recalled

Blood pressure medication voluntarily recalled

It's starting to sound like a broken record, but the U.S. Food and Drug Administration (FDA) has issued a recall of more blood pressure drugs due to the presence of a potentially cancer-causing chemical.

The recall comes about two months after Teva Pharmaceuticals recalled two of its blood pressure drugs for the same concerns.

The discovery of N-nitrosodimethylamine (NDMA) and a second impurity, N-nitrosodiethylamine (NDEA), has prompted a Europe-wide recall.

A medicine to treat blood pressure has been urgently recalled after it was found it might be contaminated with a carcinogenic chemical.

More news: Woman in vegetative state suddenly gives birth, sparking sex abuse investigation
More news: UGA QB Justin Fields transferring to Ohio State
More news: Danny Ainge Compares LeBron James to Donald Trump

The list of Valsartan products under recall can be found here and the list of Valsartan products not under recall can be found here.

The agency said that patients taking the recalled medications should keep taking their medicine until their doctor or pharmacist replaces the medications or if the doctor prescribes a different drug. On Dec. 31, 2018, the FDA announced a voluntary recall by Aurobindo Pharma USA, Inc. for 80 lots of valsartan, amlodipine-valsartan, and valsartan-hydrochlorothiazide tablets. The company says it has not received "any reports" that its drugs have actually caused cancer in any patients, but it's issuing the recall to make sure that doesn't happen in the future.

Amlodipine Valsartan Tablets USP, Valsartan HCTZ Tablets, USP and Valsartan Tablets USP are used to control high blood pressure and for the treatment of heart failure. The product can be identified by checking the product name, manufacturer details and batch or lot number on the bottle containing these products.

See the full list of lots recalled below.

Related Articles